会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明授权
    • Complexes and their compositions
    • 复合物及其组成
    • US06432928B1
    • 2002-08-13
    • US08836390
    • 1997-08-01
    • Lajos SzenteJozsef SzejtliMaria Vikmon nee KiralyJulia Szeman
    • Lajos SzenteJozsef SzejtliMaria Vikmon nee KiralyJulia Szeman
    • A61K31715
    • B82Y5/00A61K47/6951C07D305/14
    • This invention provides inclusion complexes of Taxol ((2aR-(a&agr;,4&bgr;,4&agr;&bgr;,6&bgr;,9&agr;(&agr;R*,&bgr;S*),11&agr;,12&agr;,12a&agr;,12b&agr;))-&bgr;-(benzoylamino)-&agr;-hydroxy-benzene-propanoic acid 6,12-b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclo-deca-(3,4)-benz-(1,2-b)-oxeth-9-yl-ester)) or Taxotere (butoxycarbonyl-10-desacetyl-N-debenzoyl-Taxol) or Taxus extracts formed with a cyclodextrin derivative and a co-solvent. This invention relates to pharmaceutical composition with increased water-solubility and stability. This invention provides the process for the preparation of an inclusion complex of Taxol or Taxotere or a brevifolia extract of Taxus formed with a cyclodextrin derivative and a co-solvent. This invention relates to pharmaceutical composition, containing as active ingredient an effective amount of an inclusion complex of Taxol or Taxotere or a Taxus brevifolia extract formed with a cyclodextrin derivative, preferably heptakis-2,6-0 dimethyl-&bgr;-cyclodextrin, random methylated &bgr;-cyclodextrin, succinylmethyl-&bgr;-cyclodextrin and a co-solvent together with usual filling, diluting and other auxiliaries generally used in the pharmaceutical industry.
    • 本发明提供了紫杉醇((2aR-(aalpha,4beta,4alphabeta,6beta,9alpha(αR*,βS*),11alpha,12alpha,12aalpha,12bapha))-β-(苯甲酰氨基)-α-羟基 - 苯 - 丙酸6,12-b-双(乙酰氧基)-12-(苯甲酰氧基)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-十二氢-4,11- 二羟基-4a,8,13,13-四甲基-5-氧代-7,11-亚甲基-1H-环十二烷基(3,4) - 苯并(1,2-b) - 氧代-9-基 - 酯))或泰索帝(丁氧羰基-10-脱乙酰基-N-脱苯甲酰基紫杉醇)或由环糊精衍生物和共溶剂形成的紫杉提取物。 本发明涉及具有增加的水溶性和稳定性的药物组合物。 本发明提供了制备紫杉醇或泰索帝的包合物的方法或由环糊精衍生物和助溶剂形成的紫杉属的短叶提取物的方法。 本发明涉及药物组合物,其含有有效量的紫杉醇或泰索帝或用环糊精衍生物形成的短叶紫杉提取物的有效量的混合物,优选七 - 2,6-0-二甲基-β-环糊精,随机甲基化β 环糊精,琥珀酰基甲基-β-环糊精和共溶剂,以及通常在制药工业中使用的填充,稀释和其它助剂。
    • 26. 发明授权
    • Honey powder preserving its natural aroma components
    • 蜂蜜粉保存其天然香气成分
    • US4529608A
    • 1985-07-16
    • US549205
    • 1983-11-04
    • Jozsef SzejtliMarta Tardy nee Lengyel
    • Jozsef SzejtliMarta Tardy nee Lengyel
    • A23L1/00A23L1/08A23L1/22
    • A23L27/77A23L21/25A23L27/70A23P10/43
    • A process for the preparation of honey powder preserving its natural aroma substances comprises(a) kneading 1 part by weight of honey, 0.8 part by weight of starch, pre-hydrolyzed starch or flour and 0.1-0.3 part by weight of cyclodextrin to yield a homogeneous mixture, subjecting the mixture thus obtained to thermal treatment at 100.degree. C. for 20 minutes, disintegrating the hot product obtained after thermal treatment, drying the product at a temperature of 50.degree.-55.degree. C., for 10-50 hours, adding 0.01-1.0% by weight of hydrophobic colloidal silicic acid or alkali earth stearate and grinding it to a powder; or(b) admixing 1 part by weight of honey with 6 parts by weight of a hot saturated aqueous cyclodextrin solution, freezing the homogeneous solution thus obtained, subjecting the product to lyphilization, adding 0.01-1.0% by weight of hydrophobic colloidal silicic acid or alkali earth stearate to the lyophilized product and grinding it to a powder.The advantage of the invention is that the aroma substances of honey are preserved and set free only during consumption.
    • 制备保存其天然芳香物质的蜂蜜粉的方法包括(a)捏合1重量份蜂蜜,0.8重量份淀粉,预水解淀粉或面粉和0.1-0.3重量份环糊精,得到 均匀混合,将得到的混合物在100℃下热处理20分钟,将热处理后得到的热产物分解,在50-55℃的温度下干燥产物10-50小时, 加入0.01-1.0重量%的疏水性胶体硅酸或碱土金属硬脂酸盐,并研磨成粉末; 或(b)将1重量份蜂蜜与6重量份热饱和水性环糊精溶液混合,冷却由此获得的均匀溶液,使产物进行裂解,加入0.01-1.0重量%的疏水胶体硅酸或 碱土金属硬脂酸盐加入到冻干产品中并研磨成粉末。 本发明的优点是蜂蜜的芳香物质被保存并且仅在消费期间释放。